Molly He is the Co-Founder and CEO of Element Biosciences, a multi-disciplinary startup focused on innovating genetic analysis tools and human genome sequencing. She has more than 20 years of experience in technology innovation and management in biotechnology and healthcare industries, and has sponsored initiatives encompassing research and development, operations, and life cycle management. In 2023, He was recognized for her innovative work by Forbes magazine on their "50 Over 50" list.

Prior to Element Biosciences, He was a Venture Partner at Foresite Capital; Senior Director of Scientific Research at the DNA sequencing giant Illumina; and Head of Protein Sciences at Pacific Biosciences, where she was responsible for protein reagent development for their single-molecule real-time sequencing chemistry. She also has years of experience in the pharmaceutical industry, focusing on the structure-based design of antibody and small molecule drugs targeting cancer and immune diseases.

He holds a PhD from the University of California, Los Angeles in protein biophysics. She is passionate about science and technology education and is a coach for the California State Science Olympiad competition.

Forbes, Forbes Top Lists, Biology Science, Genetics, Biotechnology, Pharmaceutical, Healthcare, Technology, Chemistry, CEO, Chief Executive Officer (CEO), Co-founder,